Literature DB >> 10970388

Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

M H Mayrand1, F Coutlée, C Hankins, N Lapointe, P Forest, M de Ladurantaye, M Roger.   

Abstract

Persistent human papillomavirus (HPV) infection of the uterine cervix is a risk factor for progression to high-grade squamous intraepithelial lesions. Detection in consecutive genital samples of HPV-16 DNA, a frequently encountered HPV type, may represent persistent infection or reinfection. We undertook a study using PCR-single-strand conformation polymorphism (SSCP) analysis and sequencing of PCR products (PCR-sequencing) to determine if consecutive HPV-16-positive samples contained the same HPV-16 variant. Fifty women (36 human immunodeficiency virus [HIV] seropositive, 14 HIV seronegative) had at least two consecutive genital specimens obtained at 6-month intervals that contained HPV-16 DNA as determined by a consensus L1 PCR assay. A total of 144 samples were amplified with two primer pairs for SSCP analysis of the entire long control region. Fifteen different SSCP patterns were identified in our population, while 22 variants were identified by PCR-sequencing. The most frequent SSCP pattern was found in 75 (53%) samples from 27 (54%) women. The SSCP patterns obtained from consecutive specimens were identical for 46 (92%) of 50 women, suggesting persistent infection. Four women exhibited in consecutive specimens different HPV-16 SSCP patterns that were all confirmed by PCR-sequencing. The additional information on the nature of persistent infection provided by molecular variant analysis was useful for 6% of women, since three of the four women who did not have identical consecutive specimens would have been misclassified as having persistent HPV-16 infection on the basis of HPV typing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970388      PMCID: PMC87391     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group.

Authors:  C Hankins; N Lapointe; S Walmsley
Journal:  CMAJ       Date:  1998-12-01       Impact factor: 8.262

3.  Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree.

Authors:  L Ho; S Y Chan; V Chow; T Chong; S K Tay; L L Villa; H U Bernard
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

4.  Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Authors:  D C Swan; R A Tucker; G Tortolero-Luna; M F Mitchell; L Wideroff; E R Unger; R A Nisenbaum; W C Reeves; J P Icenogle
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  Human papillomavirus infection is transient in young women: a population-based cohort study.

Authors:  M Evander; K Edlund; A Gustafsson; M Jonsson; R Karlsson; E Rylander; G Wadell
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

6.  Genital human papillomavirus infection in female university students as determined by a PCR-based method.

Authors:  H M Bauer; Y Ting; C E Greer; J C Chambers; C J Tashiro; J Chimera; A Reingold; M M Manos
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

7.  Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia.

Authors:  J P Icenogle; M Laga; D Miller; A T Manoka; R A Tucker; W C Reeves
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

8.  Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis.

Authors:  L F Xi; W Demers; N B Kiviat; J Kuypers; A M Beckmann; D A Galloway
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

9.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

10.  Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind.

Authors:  S Y Chan; L Ho; C K Ong; V Chow; B Drescher; M Dürst; J ter Meulen; L Villa; J Luande; H N Mgaya
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  9 in total

1.  Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Ayaka Hulbert; Mark Schiffman; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2010-10-26       Impact factor: 5.226

2.  Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies.

Authors:  R Tachezy; I Mikysková; V Ludvíková; L Rob; T Kucera; V Slavík; A Beková; H Robová; M Pluta; E Hamsíková
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

3.  Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.

Authors:  François Coutlée; Patti Gravitt; Janet Kornegay; Catherine Hankins; Harriet Richardson; Normand Lapointe; Hélène Voyer; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  The HPV16 Genome Is Stable in Women Who Progress to In Situ or Invasive Cervical Cancer: A Prospective Population-Based Study.

Authors:  Laila-Sara Arroyo-Mühr; Camilla Lagheden; Emilie Hultin; Carina Eklund; Hans-Olov Adami; Joakim Dillner; Karin Sundström
Journal:  Cancer Res       Date:  2019-07-09       Impact factor: 12.701

5.  Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.

Authors:  K S Cuschieri; H A Cubie; M W Whitley; G Gilkison; M J Arends; C Graham; E McGoogan
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

6.  Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR.

Authors:  Krzysztof Lukaszuk; Joanna Liss; Izabela Wozniak; Janusz Emerich; Czesław Wójcikowski
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  The laboratory diagnosis of genital human papillomavirus infections.

Authors:  François Coutlée; Danielle Rouleau; Alex Ferenczy; Eduardo Franco
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

Review 8.  Papillomaviruses: Viral evolution, cancer and evolutionary medicine.

Authors:  Ignacio G Bravo; Marta Félez-Sánchez
Journal:  Evol Med Public Health       Date:  2015-01-28

Review 9.  Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers.

Authors:  Maryam Soheili; Hossein Keyvani; Marzieh Soheili; Sherko Nasseri
Journal:  Med J Islam Repub Iran       Date:  2021-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.